FDA Inspection
Maiva Pharma Private LimitedMaiva Pharma Private Limited – FDA Inspection, Aug 2, 2019
Record Details
This FDA Inspection record concerns Maiva Pharma Private Limited, with an inspection on August 2, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · fa3d0036-0755-4be8-b2ee-c656333f9887
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099734
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Maiva Pharma Private Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 20, 2026 | Not classified | Office of Inspections and Investigations | |
| July 22, 2025 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| October 29, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Maiva Pharma Private Limited
- FDA Inspection 1307094 - 2026-02-20
- FDA Inspection 1276635 - 2025-07-22
- FDA Inspection 1190383 - 2022-10-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.